BAA titled, "a community based study of adverse effects of nsaids on the kidney and risk mitigation to reduce preventable harm"
Ended Definitive Contract Awarded Last action
- Contract number
- HHSF223201510132C
- Awardee
-
Albany College Of Pharmacy And Health Sciences UEI LCFLMPUNNGJ3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $199,381
Award facts
- Opportunity
-
- FDABAA1500121 Solicitation number
- Food and Drug Administration Broad Agency Announcement for the Advanced Research and Development of Regulatory Science Award Notice · Posted Feb 23, 2015
- Contract value 100% obligated
- $199,380.68 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 61 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Albany, NY 12208, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$4,352 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $135,853 | |
| Other Administrative Action | $0 | |
| Original award | $67,880 |
About this award
This is a federal contract award from the Food and Drug Administration (FDA) to the Albany College of Pharmacy and Health Sciences (ACPHS), a private non-profit educational institution. The $199,380.68 definitive contract, titled "A Community Based Study of Adverse Effects of NSAIDs on the Kidney and Risk Mitigation to Reduce Preventable Harm," was awarded on September 11, 2015 with a completion date of September 14, 2018. The contract is a cost-no-fee type and was not set aside for a specific business category. ACPHS, as the prime contractor, will perform the work in Albany, New York. The contract supports a community-based study focused on understanding and mitigating the adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) on the kidney, in line with the FDA's mission to protect public health.
Quick answers
Who was awarded contract HHSF223201510132C?
HHSF223201510132C was awarded to Albany College Of Pharmacy And Health Sciences by Food and Drug Administration (Department of Health and Human Services) on September 11, 2015.
How much is contract HHSF223201510132C worth?
The government has obligated $199,381 on HHSF223201510132C.
Was contract HHSF223201510132C competed?
The extent of competition for HHSF223201510132C was full and open competition. The government received 61 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award